Profound Medical (TSE:PRN) Shares Down 2.6% – What’s Next?

Shares of Profound Medical Corp. (TSE:PRN) dropped 2.6% on Friday . The stock traded as low as C$8.05 and last traded at C$8.57. Approximately 19,544 shares were traded during trading, a decline of 6% from the average daily volume of 20,711 shares. The stock had previously closed at C$8.80.

Profound Medical Stock Down 2.6%

The stock has a 50 day moving average of C$9.10 and a 200-day moving average of C$8.87. The firm has a market capitalization of C$311.04 million, a P/E ratio of -6.08 and a beta of 1.10. The company has a debt-to-equity ratio of 7.09, a quick ratio of 14.98 and a current ratio of 12.52.

Profound Medical (TSE:PRN) last issued its earnings results on Thursday, March 5th. The company reported C$0.37 earnings per share for the quarter. The firm had revenue of C$8.00 million during the quarter. Profound Medical had a negative net margin of 248.45% and a negative return on equity of 85.73%. Research analysts predict that Profound Medical Corp. will post -1.9000001 earnings per share for the current fiscal year.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.